D. Michael A. Wallace

3.8k total citations
103 papers, 2.6k citations indexed

About

D. Michael A. Wallace is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, D. Michael A. Wallace has authored 103 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in D. Michael A. Wallace's work include Bladder and Urothelial Cancer Treatments (50 papers), Urinary and Genital Oncology Studies (33 papers) and Urological Disorders and Treatments (13 papers). D. Michael A. Wallace is often cited by papers focused on Bladder and Urothelial Cancer Treatments (50 papers), Urinary and Genital Oncology Studies (33 papers) and Urological Disorders and Treatments (13 papers). D. Michael A. Wallace collaborates with scholars based in United Kingdom, United States and Netherlands. D. Michael A. Wallace's co-authors include Richard T. Bryan, Sarah Bathers, Lucinda Billingham, E. Boyland, D. Clive Williams, Kar Keung Cheng, Angela Risch, Edith Sim, Nicholas D. James and Kevin M. Smith and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

D. Michael A. Wallace

100 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Michael A. Wallace United Kingdom 29 1.4k 694 449 432 428 103 2.6k
Robert R. Bahnson United States 27 696 0.5× 407 0.6× 320 0.7× 1.1k 2.7× 385 0.9× 96 2.5k
Piyush K. Agarwal United States 33 1.3k 0.9× 716 1.0× 303 0.7× 1.2k 2.7× 461 1.1× 155 3.0k
Jay B. Shah United States 28 1.4k 1.0× 620 0.9× 320 0.7× 532 1.2× 715 1.7× 84 2.6k
Yoshiyuki Matsui Japan 27 1.0k 0.7× 679 1.0× 630 1.4× 733 1.7× 444 1.0× 178 2.6k
Shinichi Yamashita Japan 26 512 0.4× 719 1.0× 165 0.4× 968 2.2× 411 1.0× 154 2.2k
F. Edsmyr Sweden 23 794 0.6× 245 0.4× 236 0.5× 300 0.7× 405 0.9× 90 1.6k
Michael J. Manyak United States 24 400 0.3× 258 0.4× 463 1.0× 984 2.3× 201 0.5× 84 2.0k
Noriyasu Kawai Japan 21 469 0.3× 503 0.7× 132 0.3× 760 1.8× 381 0.9× 137 1.9k
S.J. Harland United Kingdom 21 859 0.6× 511 0.7× 96 0.2× 668 1.5× 664 1.6× 39 2.2k
T.R. Leyshon Griffiths United Kingdom 25 1.2k 0.9× 850 1.2× 297 0.7× 705 1.6× 474 1.1× 67 2.3k

Countries citing papers authored by D. Michael A. Wallace

Since Specialization
Citations

This map shows the geographic impact of D. Michael A. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Michael A. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Michael A. Wallace more than expected).

Fields of papers citing papers by D. Michael A. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Michael A. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Michael A. Wallace. The network helps show where D. Michael A. Wallace may publish in the future.

Co-authorship network of co-authors of D. Michael A. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of D. Michael A. Wallace. A scholar is included among the top collaborators of D. Michael A. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Michael A. Wallace. D. Michael A. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Parsonage, Greg, Rupesh I. Bhatt, D. Michael A. Wallace, et al.. (2011). T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6. European Urology. 61(2). 385–394. 77 indexed citations
4.
Bryan, Richard T., Wenbin Wei, Neil J. Shimwell, et al.. (2011). Assessment of high‐throughput high‐resolution MALDI‐TOF‐MS of urinary peptides for the detection of muscle‐invasive bladder cancer. PROTEOMICS - CLINICAL APPLICATIONS. 5(9-10). 493–503. 28 indexed citations
5.
Patel, Prashant, Vivien Mautner, Sarah Bonney, et al.. (2009). A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984. Molecular Therapy. 17(7). 1292–1299. 92 indexed citations
6.
Wallace, D. Michael A., Masayuki Haramura, Jie‐Fei Cheng, Thomas Arrhenius, & Alex M. Nadzan. (2007). Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(4). 1127–1130. 8 indexed citations
7.
Harland, S.J., Howard Kynaston, Kenneth M. Grigor, et al.. (2007). A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 178(3). 807–813. 46 indexed citations
8.
Wirth, Manfred P., C. Tyrrell, K.P.J. Delaere, et al.. (2006). Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up. Prostate Cancer and Prostatic Diseases. 10(1). 87–93. 22 indexed citations
9.
Pankhurst, Tanya, Alexander J. Howie, Dwomoa Adu, D. Michael A. Wallace, & Graham Lipkin. (2005). Incidental neoplasms in renal biopsies. Nephrology Dialysis Transplantation. 21(1). 64–69. 8 indexed citations
10.
Bryan, Richard T., Syed A. Hussain, Nicholas D. James, Janusz Jankowski, & D. Michael A. Wallace. (2005). Molecular pathways in bladder cancer: Part 2. British Journal of Urology. 95(4). 491–496. 23 indexed citations
11.
Greenland, Jonathan, P. M. T. WESTON, & D. Michael A. Wallace. (1993). Familial Transitional Cell Carcinoma and the Lynch Syndrome II. British Journal of Urology. 72(2). 177–180. 6 indexed citations
12.
Lynch, Thomas, et al.. (1992). Urologists' Attitudes to the Management of Bladder Cancer. British Journal of Urology. 70(5). 522–525. 5 indexed citations
13.
WESTON, P. M. T., Jonathan Greenland, & D. Michael A. Wallace. (1992). Chylous Ascites following Retroperitoneal Lymph Node Dissection for Testis Cancer. British Journal of Urology. 70(6). 688–689. 9 indexed citations
14.
Lynch, Thomas, et al.. (1991). Follow up after transurethral resection of prostate: who needs it?. BMJ. 302(6767). 27–27. 13 indexed citations
15.
Wallace, D. Michael A., et al.. (1990). REVIEW ARTICLE THERAPEUTIC PROGRESS–REVIEW XXXVI: ARE WE MAKING PROGRESS IN THE DRUG TREATMENT OF DISORDERS OF THE BLADDER, PROSTATE, and PENIS?. Journal of Clinical Pharmacy and Therapeutics. 15(1). 1–12. 1 indexed citations
16.
Conn, I.G., J Crocker, D. Michael A. Wallace, M. A. HUGHES, & Christie Hilton. (1987). Basement Membranes in Urothelial Carcinoma. British Journal of Urology. 60(6). 536–542. 46 indexed citations
17.
Wallace, D. Michael A.. (1972). Urothelial neoplasia. Causes, assessment, and treatment.. PubMed. 51(2). 91–102. 3 indexed citations
18.
Wallace, D. Michael A.. (1970). URETERO‐ILEOSTOMY. British Journal of Urology. 42(5). 529–534. 60 indexed citations
19.
Wallace, D. Michael A., et al.. (1968). Cancer of the prostate. REAL-EOD (Library of the Hungarian Academy of Sciences and the Information Center Oriental Collection). 8 indexed citations
20.
Wallace, D. Michael A.. (1959). Tumours of Bladder. Europe PMC (PubMed Central). 38(8). 727–738. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert R. Bahnson Breakdown of academic impact, for papers by Piyush K. Agarwal Breakdown of academic impact, for papers by Jay B. Shah Breakdown of academic impact, for papers by Yoshiyuki Matsui Breakdown of academic impact, for papers by Shinichi Yamashita Breakdown of academic impact, for papers by F. Edsmyr Breakdown of academic impact, for papers by Michael J. Manyak Breakdown of academic impact, for papers by Noriyasu Kawai Breakdown of academic impact, for papers by S.J. Harland Breakdown of academic impact, for papers by T.R. Leyshon Griffiths
Rankless by CCL
2026